News
FDA asks Sarepta to stop shipping gene therapy
Digest more
32m
News Medical on MSNGene editing in the brain offers hope for ultra-rare neurological diseaseScientists have corrected gene mutations in mice causing an ultra-rare disease by editing DNA directly in the brain with a ...
Ocugen has dosed the first subject in its Phase II/III GARDian3 trial of modifier gene therapy candidate, OCU410ST ...
A team of Chinese medical experts say they can produce anti-cancer cells directly inside the human body using gene therapy ...
Massachusetts-based Sarepta Therapeutics, facing scrutiny from regulators, is reducing its global workforce by 36% in an ...
Our Bureau, Mumbai Friday, July 18, 2025, 17:45 Hrs [IST] ...
The Centers for Medicare and Medicaid Services (CMS) has selected 35 participants for its new, voluntary Cell and Gene ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results